All Posts: neuroscience
-
Maguire-Zeiss Named New Chair of Department of Neuroscience
(August 29, 2019) — Since joining Georgetown’s faculty in 2007, Kathy Maguire-Zeiss, PhD, has taken on many roles. In addition to being a professor of neuroscience, she directs the Interdisciplinary Program in Neuroscience (IPN), the Center for Neural Injury and Recovery, the master’s degree program in integrative neuroscience and the T32 Training Program in Neural […]
Category: GUMC Stories
-
Georgetown’s Memory Disorders Program Marks 20th Year
(April 12, 2019) — When President Ronald Reagan announced in 1994 that he had Alzheimer’s disease, the man known as the “great communicator” tried his best to convey a sense of optimism. “I now begin the journey that will lead me into the sunset of my life. I know that for America there will always […]
Category: GUMC Stories
-
MCGSO Welcomes Hardy Middle School During Brain Awareness Week
(March 29, 2019) — In an effort to promote brain research and awareness, the Medical Center Graduate Student Organization (MCGSO) hosted more than 100 seventh graders from a local middle school for a full day of creative, interactive brain-related activities and demonstrations. The March 14 visit to Georgetown gave MCGSO members a potent opportunity to […]
Category: GUMC Stories
-
Researchers Decode How Cancer Drug Works in Brains of Parkinson’s Disease Patients
MEDIA CONTACT:Karen Teberkm463@georgetown.edu WASHINGTON (March 12, 2019) — Laboratory analysis from the first arm of a phase II clinical trial testing the use of nilotinib in patients with Parkinson’s disease demonstrates precisely how the agent increases levels of dopamine in the brains of study participants, says a research team at Georgetown University Medical Center. Symptoms […]
Category: News Release
-
Georgetown Physician Leads International Experts in Developing Treatment Guidelines for Huntington’s Disease Symptoms
(February 1, 2019) — A group of international experts in Huntington’s disease, led by Georgetown University Medical Center’s Karen Anderson, MD, has developed consensus guidelines for the clinical management of behavior symptoms caused by the incurable disease. Huntington’s disease is a fatal genetic disorder that impacts a person’s physical and mental abilities that is often accompanied […]
Category: GUMC Stories
-
Researchers Find Inhibiting One Protein Destroys Toxic Clumps Seen in Parkinson’s Disease
MEDIA CONTACT (ONLY, PLEASE):Karen Teberkm463@georgetown.edu WASHINGTON (November 14, 2018) — A defining feature of Parkinson’s disease is the clumps of alpha-synuclein protein that accumulate in the brain’s motor control area, destroying dopamine-producing neurons. Natural processes can’t clear these clusters, known as Lewy bodies, and no one has demonstrated how to stop the build up as well […]
Category: News Release
-
Georgetown Study Investigates Memory Improvement Through Nicotine Dosing
A new study being conducted at Georgetown University Medical Center aims to find out if nicotine can slow or stop memory loss in people experiencing mild memory problems.
Category: News Release
-
Making Sense of Senses: Researchers Find the Brain Processes Sight and Sound in the Same Two-Step Manner
A new study published by senior investigator Maximilian Riesenhuber, PhD, a professor in Georgetown University School of Medicine’s Department of Neuroscience, and fellow Georgetown neuroscientists Xiong Jiang, PhD; Mark A. Chevillet; and Josef P. Rauschecker, PhD, is the first to provide strong evidence that learning in sight and sound follows similar principles.
Category: News Release
-
If Your Child is Bilingual, Learning Additional Languages Later Might be Easier
It is often claimed that bilinguals are better than monolinguals at learning languages. Now, the first study to examine bilingual and monolingual brains as they learn an additional language offers new evidence that supports this hypothesis, researchers say.
Category: News Release
-
Agent Clears Toxic Proteins, Reduces Inflammation and Improves Cognition in Neurodegeneration Models
LONDON (July 16, 2017) — Researchers have found cell receptors abnormally overexpressed in post-mortem brains of those with Parkinson’s and Alzheimer’s diseases, and that they can be inhibited in animal models to clear toxic protein buildup, reduce brain inflammation, and improve cognitive performance. These dual findings, presented by Georgetown University Medical Center (GUMC) researchers at […]
Category: News Release